Reminds me of Paul Keating calling John Hewson Mr Magoo because he thought he lacked vision. I can’t help but think that Alterity are lacking vision given their response to your query.
I will have to respectfully disagree with you on this. Whilst i believe that the University of Queensland (UoQ) is still doing great work in the field of antimicrobial resistance, it is now up to Alterity to commercialise UoQ’s novel zinc ionophore technology in conjunction with PBT2. UniQuest’s role has largely finished. In the Alterity’s announcement on 21 Dec 20, it was UniQuest who granted access to Alterity for the use of UoQ’s zinc ionophore technology. Until recently, i was allowing for the possibility that Alterity was waiting for more research by UoQ before going to the FDA for guidance but this does not seem to be the case.
ATH Price at posting:
2.0¢ Sentiment: Hold Disclosure: Held
(20min delay)